Summary:

- Myasthenia Gravis is a rare autoimmune disorder that affects the communication between nerves and muscles, leading to muscle weakness.
- The article discusses the expected growth of the Myasthenia Gravis market, which is estimated to grow at a Compound Annual Growth Rate (CAGR) of 10.4% by 2034.
- This growth is attributed to the development of new and improved treatments, increased awareness, and the rising prevalence of the disease.